252 related articles for article (PubMed ID: 27924833)
1. TGFβ2-induced outflow alterations in a bioengineered trabecular meshwork are offset by a rho-associated kinase inhibitor.
Torrejon KY; Papke EL; Halman JR; Bergkvist M; Danias J; Sharfstein ST; Xie Y
Sci Rep; 2016 Dec; 6():38319. PubMed ID: 27924833
[TBL] [Abstract][Full Text] [Related]
2. ROCK inhibitors beneficially alter the spatial configuration of TGFβ2-treated 3D organoids from a human trabecular meshwork (HTM).
Ota C; Ida Y; Ohguro H; Hikage F
Sci Rep; 2020 Nov; 10(1):20292. PubMed ID: 33219246
[TBL] [Abstract][Full Text] [Related]
3. TGFβ2 Induces the Formation of Cross-Linked Actin Networks (CLANs) in Human Trabecular Meshwork Cells Through the Smad and Non-Smad Dependent Pathways.
Montecchi-Palmer M; Bermudez JY; Webber HC; Patel GC; Clark AF; Mao W
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):1288-1295. PubMed ID: 28241317
[TBL] [Abstract][Full Text] [Related]
4. A tissue-engineered human trabecular meshwork hydrogel for advanced glaucoma disease modeling.
Li H; Bagué T; Kirschner A; Strat AN; Roberts H; Weisenthal RW; Patteson AE; Annabi N; Stamer WD; Ganapathy PS; Herberg S
Exp Eye Res; 2021 Apr; 205():108472. PubMed ID: 33516765
[TBL] [Abstract][Full Text] [Related]
5. TGFbeta2-induced changes in human trabecular meshwork: implications for intraocular pressure.
Fleenor DL; Shepard AR; Hellberg PE; Jacobson N; Pang IH; Clark AF
Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):226-34. PubMed ID: 16384967
[TBL] [Abstract][Full Text] [Related]
6. Ex-vivo cultured human corneoscleral segment model to study the effects of glaucoma factors on trabecular meshwork.
Kasetti RB; Patel PD; Maddineni P; Zode GS
PLoS One; 2020; 15(6):e0232111. PubMed ID: 32579557
[TBL] [Abstract][Full Text] [Related]
7. Thrombospondin-2 is up-regulated by TGFβ2 and increases fibronectin expression in human trabecular meshwork cells.
Kennedy SM; Sheridan C; Kearns VR; Bilir EK; Fan X; Grierson I; Choudhary A
Exp Eye Res; 2019 Dec; 189():107820. PubMed ID: 31589839
[TBL] [Abstract][Full Text] [Related]
8. Effects of Toll-Like Receptor 4 Inhibition on Transforming Growth Factor-β2 Signaling in the Human Trabecular Meshwork.
Sharma TP; Curry S; McDowell CM
J Ocul Pharmacol Ther; 2020 Apr; 36(3):170-178. PubMed ID: 31834824
[No Abstract] [Full Text] [Related]
9. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
[TBL] [Abstract][Full Text] [Related]
10. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao PV; Deng PF; Kumar J; Epstein DL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
[TBL] [Abstract][Full Text] [Related]
11. ID1 and ID3 are Negative Regulators of TGFβ2-Induced Ocular Hypertension and Compromised Aqueous Humor Outflow Facility in Mice.
Mody AA; Millar JC; Clark AF
Invest Ophthalmol Vis Sci; 2021 May; 62(6):3. PubMed ID: 33938911
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of TGFbeta2- and/or BMP7-treated trabecular meshwork cells: Identification of Smad7 as a critical inhibitor of TGF-beta2 signaling.
Fuchshofer R; Stephan DA; Russell P; Tamm ER
Exp Eye Res; 2009 Jun; 88(6):1020-32. PubMed ID: 19450457
[TBL] [Abstract][Full Text] [Related]
13. Effects of TGF-beta2, BMP-4, and gremlin in the trabecular meshwork: implications for glaucoma.
Wordinger RJ; Fleenor DL; Hellberg PE; Pang IH; Tovar TO; Zode GS; Fuller JA; Clark AF
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1191-200. PubMed ID: 17325163
[TBL] [Abstract][Full Text] [Related]
14. BMP and Activin Membrane Bound Inhibitor Regulates the Extracellular Matrix in the Trabecular Meshwork.
Hernandez H; Millar JC; Curry SM; Clark AF; McDowell CM
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):2154-2166. PubMed ID: 29801150
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk Between Transforming Growth Factor Beta-2 and Toll-Like Receptor 4 in the Trabecular Meshwork.
Hernandez H; Medina-Ortiz WE; Luan T; Clark AF; McDowell CM
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1811-1823. PubMed ID: 28346614
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral gene transfer of active human transforming growth factor-{beta}2 elevates intraocular pressure and reduces outflow facility in rodent eyes.
Shepard AR; Millar JC; Pang IH; Jacobson N; Wang WH; Clark AF
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2067-76. PubMed ID: 19959644
[TBL] [Abstract][Full Text] [Related]
17. A Novel Mouse Model of TGFβ2-Induced Ocular Hypertension Using Lentiviral Gene Delivery.
Patil SV; Kasetti RB; Millar JC; Zode GS
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805889
[TBL] [Abstract][Full Text] [Related]
18. Pressure-induced expression changes in segmental flow regions of the human trabecular meshwork.
Vranka JA; Acott TS
Exp Eye Res; 2017 May; 158():67-72. PubMed ID: 27334250
[TBL] [Abstract][Full Text] [Related]
19. Involvement of RhoA/Rho-associated kinase signal transduction pathway in dexamethasone-induced alterations in aqueous outflow.
Fujimoto T; Inoue T; Kameda T; Kasaoka N; Inoue-Mochita M; Tsuboi N; Tanihara H
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7097-108. PubMed ID: 22969074
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension.
Hernandez H; Roberts AL; McDowell CM
Exp Eye Res; 2020 Feb; 191():107920. PubMed ID: 31923415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
